Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Clinical trial NCT01169584 · COMPLETED

Trial details

NCT number: NCT01169584
Sponsor: Jennerex Biotherapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroblastoma Rhabdomyosarcoma Lymphoma Wilm's Tumor Ewing's Sarcoma

Start date: 2010-08-01
Primary completion: 2012-03-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.